BPTS - long - catalyst - low floater playBiophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administer
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.2206 EUR
−17.03 M EUR
0.00 EUR
5.60 M
About BIOPHYTIS
Sector
CEO
Stanislas Veillet
Headquarters
Paris
Website
Founded
2006
ISIN
FR001400OLP5
FIGI
BBG009J35BW8
Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALBPS is 0.3400 EUR — it has increased by 1.19% in the past 24 hours. Watch BIOPHYTIS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange BIOPHYTIS stocks are traded under the ticker ALBPS.
ALBPS stock has risen by 6.25% compared to the previous week, the month change is a 13.33% rise, over the last year BIOPHYTIS has showed a −86.51% decrease.
ALBPS reached its all-time high on Aug 5, 2015 with the price of 7,719.9996 EUR, and its all-time low was 0.2800 EUR and was reached on Oct 30, 2024. View more price dynamics on ALBPS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALBPS stock is 4.26% volatile and has beta coefficient of 1.13. Track BIOPHYTIS stock price on the chart and check out the list of the most volatile stocks — is BIOPHYTIS there?
Today BIOPHYTIS has the market capitalization of 1.93 M, it has increased by 2.63% over the last week.
Yes, you can track BIOPHYTIS financials in yearly and quarterly reports right on TradingView.
BIOPHYTIS is going to release the next earnings report on Feb 24, 2025. Keep track of upcoming events with our Earnings Calendar.
ALBPS net income for the last half-year is −5.81 M EUR, while the previous report showed −9.26 M EUR of net income which accounts for 37.25% change. Track more BIOPHYTIS financial stats to get the full picture.
No, ALBPS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALBPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOPHYTIS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOPHYTIS technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOPHYTIS stock shows the sell signal. See more of BIOPHYTIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.